abhilash chiramel

Head of Laboratory of Therapeutic Virus Development at Boerhinger Ingelheim.

[abhilash chiramel @AChiramel]

@VirusesImmunity @MichaelPelusoMD @microbeminded2 @PutrinoLab @Invivyd Meaning that individuals with long COVID can harbour subgenomic “replicons” coding for spike?

[abhilash chiramel @AChiramel]

@VirusesImmunity @jkagan1 @Lo_Zanzi @YYexin @SciImmunology Great work! Can these glycan-reactive IgMs also recognize syncytins?

[abhilash chiramel @AChiramel]

@casanova_lab @JExpMed @HarrisProgram Also Ted Pierson at the NIH

[abhilash chiramel @AChiramel]

@casanova_lab @JExpMed The ideal people to help test this is @HarrisProgram https://t.co/BioXiz8Xuj

[Rafeeque @rafeequemavoor]

Free scientific illustrations for biologists! 😍

@NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations!

all freely available in the public domain.

Retweet and spread the message!
https://t.co/p1bD1kxO7H

[abhilash chiramel @AChiramel]

@jkagan1 @globalimmuno @harvardmed @Harvard_Imm Great talk! Do you achieve similar hyperactivation of DCs with RLR agonists or cGAS-STING agonists in combination with PGPC?

[abhilash chiramel @AChiramel]

@casanova_lab what are the risks of triggering auto-antibodies against type 1 IFN when using an oncolytic virus expressing IFNb as payload, e.g. VSV-IFNb-NIS currently in trials.

[abhilash chiramel @AChiramel]

@casanova_lab Great work!

Would it make sense to screen patients for auto-antibodies against type 1 interferon before administering an oncolytic virus?

[abhilash chiramel @AChiramel]

@ashwinakurian @ankitatIIMA @ShubhankarM @eShailendra The Indian Council of Medical Research (ICMR) needs proper funding to allow innovation in biomedical research and biopharmaceutical manufacturing to go from bench to beside. We need a regulatory runway for speed to clinic to take off in India. @kiranshaw

[abhilash chiramel @AChiramel]

@RichardDawkins Autophagy.

[abhilash chiramel @AChiramel]

@ImmunityCP @jbloom_lab Great work! Are the natural Lassa GPC sequences with antibody-escape mutations, also conserved in LCMV?

[abhilash chiramel @AChiramel]

@jkagan1 What happens to the myddosome scaffold as a consequence of immune-editing in cancer?

[abhilash chiramel @AChiramel]

@TheBinderLab Great shot! Nice to spot Ralf in there.

[Kurian Lab @KurianLab]

👇🏾 use this opportunity please

If you would like academic career advice tailored for Germany, especially as a non-german, please contact me. I am happy to help. I can definitely tell you what all I did wrong in my early applications

[abhilash chiramel @AChiramel]

@jkagan1 Very nice work. Is C192 conserved in function across other Gasdermins, example GSDME?

[abhilash chiramel @AChiramel]

@schumacherbj That looks like a Björn Again Schumacher

[abhilash chiramel @AChiramel]

@XinGu0317 @ScienceMagazine Fantastic work! Would be interesting to investigate the substrate landscape of the pathway in the presence of interferon.

[abhilash chiramel @AChiramel]

@Iyervval Went from being @prakashraaj to @prakASSraj. @smitaprakash worth an interview?

[abhilash chiramel @AChiramel]

@prakashraaj It’s a pitty how you see Indian scientists. It’s not easy what they’re attempting and keeping it economically viable at the same time. Be responsible with your posts.